Ruixian Peng - Concepedia

Author

Ruixian Peng

Also Known As

R. Peng, RUIXIAN PENG, Rui-xian Peng, Ruixian Peng

Publications

120

Citations

H-Index

Concepts

All Affiliations

Ruixian Peng is an author at Fudan University specializing in cell biology, drug discovery, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	43
2	Cell Biology	2	2	43
3	Pharmacology	2	2	43
4	Cancer Therapeutics	2	2	43
5	Cancer Cell Biology	1	1	10

Ruixian Peng

Publications

113

Citations

H-Index

Page 1

	Year	Citations
Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells Qiang Wang, Ruixian Peng, Boshi Wang, Cancer Biomarkers	2018	38
17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation Jifeng Wang, Zhenyu Li, Zhiyuan Lin, Cancer Letters Survivin DownregulationOncologyMedicineAnti-cancer AgentHsp90 Inhibition	2015	33
Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein Jun Zhang, Xilong Wang, Yangyun Wang, Oncology Letters	2017	17
17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition Zhiyuan Lin, Ruixian Peng, Zhenyu Li, International Journal of Molecular Medicine	2015	15
The HSP90 inhibitor 17-PAG effectively inhibits the proliferation and migration of androgen-independent prostate cancer cells. Ruixian Peng, Zhenyu Li, Zhiyuan Lin, PubMed UrologyOncologyEndocrine-related CancerMedicinePharmacology	2015	10

Page 1